Navigation Links
ConvaTec and HemCon Announce Co-Promotion Agreement
Date:4/15/2009

nd ConvaTec USA. "We hope this agreement also will form the basis of similar initiatives to expand our presence in specialized, acute care settings."

"This new arrangement with ConvaTec will provide the U.S. Armed Forces with the support and products they need to enable safer, more stable recoveries," said Bill Block, President, HemCon U.S. "As a trusted, proven Military partner, HemCon continues to pioneer and deliver new products for wound care and healing that bring innovative solutions to the Military and deliver medical technologies when and where they are needed most."

About ConvaTec

ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key business divisions -- Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices -- ConvaTec products support health care professionals from the hospital to the community health setting. From its headquarters in Skillman, New Jersey, the company oversees more than 8,000 employees in over 90 countries serving consumers and their health care professionals on six continents. For more information, please visit www.convatec.com.

About HemCon Medical Technologies

HemCon Medical Technologies Inc. is a leading global developer of advanced medical products designed to improve the standard of patient care. The company is responsible for developing the chitosan-based HemCon dressing used by thousands of military and civilian first responders and is changing wound care best practices in hospital, dental and clinical settings. In addition, HemCon is leading the charge to develop and license unique, life-saving medical advances including Lyophilized Human Plasma and Nanospider(TM) technologies. HemCon is headquartered in Portland, OR, with additiona
'/>"/>

SOURCE ConvaTec
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. ConvaTec Launches SUR-FIT Natura(R) Low-Pressure Adaptor
2. ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
3. ConvaTec Launches New Lifestyle Magazine for People With an Ostomy
4. ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
5. ConvaTec Announces Divestiture of Unomedical Wound Care and Ophthalmics Business
6. ConvaTec Names Paul Moraviec President, Continence and Critical Care Business Unit and ConvaTec EMEA Region
7. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
8. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
9. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
10. HEI, Inc. Announces Sale of RFID Division Assets
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
(Date:12/4/2009)Outcomes same whether procedure done immediately or 3 weeks later, study shows , , FRIDAY, Dec. 4 (HealthDay News) -- Timing of surgical repair or reconstruction of multiple-ligament knee inju
(Date:12/4/2009)Move a response to pressure from federal regulators to crack down on abuse of opioid medications , , FRIDAY, Dec. 4 (HealthDay News) -- The makers of 24 different prescription painkillers on F
(Date:12/4/2009)Dr. Redlener Applauds Historic Effort but Points out Potential Risk if America,s Safety Net Programs Are Lost in Final Health Care Reform ,, NEW YORK, Dec. 4 The New England Journal of Medicine
(Date:12/4/2009)Whether the H1N1 virus will come back during winter isn,t known, CDC says, , , FRIDAY, Dec. 4 (HealthDay News) -- The number of states reporting widespread swine flu activity continued to decl
Breaking Medicine News(10 mins):Health News:Are angry women more like men? 2Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2Health News:Makers of Powerful Painkillers Present Safety Plans 2Health News:New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform 2Health News:Swine Flu Continues to Wane 2
...sparked new fears over the safety of Scottish farm...o more than two portions a year.// Researche...tate University, concluded that the health benefit...e health risks will outweigh the benefits, accordi...
...accident has been described as an environmental tr...he blaze. The flames are reportedly spewing out a ...her explosion from a highly volatile fuel tank led...50 fire service personnel drawn from 16 fire servi...
...y the common cold, according to a Newcastle Univer...caused by relatively minor ailments like a respira...ore in the case of those who are genetically susce...nt of a vaccine which will serve to protect childr...
...Palliative care for treatment of chronic diseases ...itals, which has been reported in the Journal of P...patients where chemotherapy or other treatments no...r palliative care. Palliative care programs prov...
...d a non-invasive sensor that will help treat patie... When a patient faces respiratory distress in ... concentrations of oxygen via a mask. But for some...es precious minutes, but the non-invasive sensor c...
...the death of Rene Anderson who took part in a tria...x drug is derived from the plant, and it has been ...ministered to Rene Anderson for relieving her of p...pneumonia and kidney failure. The manufacturers of...
Other Medicine News:Health News:Salmon's own diet sure to affect yours 2Health News:Firefighters Continue To Battle Blaze 2
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)SALT LAKE CITY, Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ) announced it has signed a sole-source vendor agreement to provide therapy equipment and rehab supplies to Benchmark Physical Therapy wi
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5Regence Launches Effort to Further Health Care Debate 51852 1Regence Launches Effort to Further Health Care Debate 51852 2Regence Launches Effort to Further Health Care Debate 51852 3Industry Veterans Rash and Rutledge Launch RegionalCare Hospital Partners to Acquire and Operate Hospitals in Non Urban Markets 51850 1Industry Veterans Rash and Rutledge Launch RegionalCare Hospital Partners to Acquire and Operate Hospitals in Non Urban Markets 51850 2Industry Veterans Rash and Rutledge Launch RegionalCare Hospital Partners to Acquire and Operate Hospitals in Non Urban Markets 51850 3Industry Veterans Rash and Rutledge Launch RegionalCare Hospital Partners to Acquire and Operate Hospitals in Non Urban Markets 51850 4Cornerstone Therapeutics Submits Regulatory Filing for Extended Release Antitussive Product 51848 1Cornerstone Therapeutics Submits Regulatory Filing for Extended Release Antitussive Product 51848 2Cornerstone Therapeutics Submits Regulatory Filing for Extended Release Antitussive Product 51848 3Cornerstone Therapeutics Submits Regulatory Filing for Extended Release Antitussive Product 51848 4Cornerstone Therapeutics Submits Regulatory Filing for Extended Release Antitussive Product 51848 5
...SEARCH TRIANGLE PARK, N.C., July 27 Timothy Mastr...tional (FHI) on August 1st,as Senior Director of R...rch into pre-exposure prophylaxis (PrEP) for HIV p...Mexico City., Dr. Mastro,s presentation, titled "...ls," will examine ongoing and upcoming clinical tr...
...nancing will advance the company,s clinical develo... technology platform, PRINCETON, N.J., July 28 C...tical company developing novel,products based on p...y,announced that it raised in excess of $22.5 mill...Series B investors participated in the financing a...
Other Medicine Technology:HIV Prevention Expert Dr. Timothy Mastro Speaks on Future of Pre-Exposure Prophylaxis at International AIDS Conference 2Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million 2Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million 3
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: